Company Information

CIN
Status
Date of Incorporation
03 January 2006
State / ROC
Ahmedabad / ROC Ahmedabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
26 September 2023
Paid Up Capital
31,725,020
Authorised Capital
50,000,000

Directors

Sanjaykumar Kanjibhai Patel
Sanjaykumar Kanjibhai Patel
Director/Designated Partner
over 2 years ago
Tej Krishen Bazaz
Tej Krishen Bazaz
Director/Designated Partner
about 4 years ago

Past Directors

Subashri Shivkumar
Subashri Shivkumar
Additional Director
almost 4 years ago
Harshal Kirtibhai Shah
Harshal Kirtibhai Shah
Director
about 9 years ago
Neeru Rupesh Madan
Neeru Rupesh Madan
Director
about 14 years ago
Pramod Kabra
Pramod Kabra
Director
about 14 years ago
Amit Chopra
Amit Chopra
Director
about 14 years ago
Paresh Kumar Gupta
Paresh Kumar Gupta
Company Secretary
about 15 years ago
Arvind Raghunath Sonawane
Arvind Raghunath Sonawane
Director
about 16 years ago

Registered Trademarks

Fisher Clinical Services Fisher Biopharma Services India

[Class : 42] Managing And Administering The Manufacture And Packaging Of Candidate Drug Compounds, Placebos, Comparator Compounds And Control Compounds Used In Conducting Clinical Trials Of Human And Veterinary Pharmaceutical Products, Managing And Administering The Distribution Of Candidate Drug Compounds, Placebos, Comparator Compounds And Control Compounds To Clinical Inv...

Fisher Fisher Biopharma Services India

[Class : 42] Consultancy, Research And Advisory Services Related To The Manufacture And Packaging Of Candidate Drug Compounds, Placebos, Comparator Compounds And Control Compounds Used In Conducting Clinical Trials Of Human And Veterinary Pharmaceutical Product; The Distribution Of Candidate Drug Compounds, Placebos, Comparator Compounds And Control Compounds To Clinical Inv...

Documents

Copy of MGT-8-29122020
List of share holders, debenture holders;-29122020
Optional Attachment-(1)-29122020
Form MGT-7-29122020_signed
Company CSR policy as per section 135(4)-28122020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-28122020
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-28122020
Details of other Entity(s)-28122020
Directors report as per section 134(3)-28122020
Copy of financial statements duly authenticated as per section 134(including Board?s report, auditors? report and other documents)-28122020
Form AOC-4-28122020_signed
Form AOC-4 additional attachment-28122020_signed
Form MSME FORM I-24112020_signed
Form DPT-3-02122019-signed
Form MSME FORM I-17112019_signed
Form AOC-4-16112019_signed
List of share holders, debenture holders;-12112019
Copy of MGT-8-12112019
Form MGT-7-12112019_signed
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-25102019
Directors report as per section 134(3)-25102019
Company CSR policy as per section 135(4)-25102019
Details of other Entity(s)-25102019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-25102019
Form ADT-1-15102019_signed
Optional Attachment-(1)-14102019
Copy of resolution passed by the company-14102019
Copy of written consent given by auditor-14102019
Copy of the intimation sent by company-14102019
Form MSME FORM I-21062019_signed